ZA936695B - Absorbate of an auxiliary mixture and non-solid active compound for the preparation of pharmaceutical compositions - Google Patents

Absorbate of an auxiliary mixture and non-solid active compound for the preparation of pharmaceutical compositions

Info

Publication number
ZA936695B
ZA936695B ZA936695A ZA936695A ZA936695B ZA 936695 B ZA936695 B ZA 936695B ZA 936695 A ZA936695 A ZA 936695A ZA 936695 A ZA936695 A ZA 936695A ZA 936695 B ZA936695 B ZA 936695B
Authority
ZA
South Africa
Prior art keywords
absorbate
preparation
pharmaceutical compositions
active compound
solid active
Prior art date
Application number
ZA936695A
Other languages
English (en)
Inventor
Theophil Hornykiewytsch
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA936695B publication Critical patent/ZA936695B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA936695A 1992-09-11 1993-09-10 Absorbate of an auxiliary mixture and non-solid active compound for the preparation of pharmaceutical compositions ZA936695B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4230371 1992-09-11

Publications (1)

Publication Number Publication Date
ZA936695B true ZA936695B (en) 1994-04-05

Family

ID=6467712

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936695A ZA936695B (en) 1992-09-11 1993-09-10 Absorbate of an auxiliary mixture and non-solid active compound for the preparation of pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP0587137A1 (enExample)
JP (1) JPH06192093A (enExample)
KR (1) KR940006583A (enExample)
AU (1) AU663000B2 (enExample)
CA (1) CA2105913A1 (enExample)
FI (1) FI933954L (enExample)
HU (1) HUT67577A (enExample)
IL (1) IL106953A0 (enExample)
MX (1) MX9305578A (enExample)
NO (1) NO933237L (enExample)
NZ (1) NZ248627A (enExample)
TW (1) TW222585B (enExample)
ZA (1) ZA936695B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ267002A (en) * 1993-06-04 1997-07-27 Warner Lambert Co Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide
US5626878A (en) * 1995-01-10 1997-05-06 Warner Lambert Company Reduction of electrostatic forces between magnesium trisilicate adsorbates
BR9916361A (pt) * 1998-12-18 2002-11-05 Abbott Lab Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
EP1765297A2 (en) * 2004-06-28 2007-03-28 LifeCycle Pharma A/S Porous tablets as carriers for liquid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern
DE3924093A1 (de) * 1989-07-20 1991-02-07 Hoechst Ag N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms

Also Published As

Publication number Publication date
EP0587137A1 (de) 1994-03-16
NO933237D0 (no) 1993-09-10
HU9302555D0 (en) 1993-11-29
FI933954A7 (fi) 1994-03-12
TW222585B (enExample) 1994-04-21
MX9305578A (es) 1994-03-31
NO933237L (no) 1994-03-14
IL106953A0 (en) 1993-12-28
KR940006583A (ko) 1994-04-25
FI933954L (fi) 1994-03-12
AU4626293A (en) 1994-03-17
JPH06192093A (ja) 1994-07-12
HUT67577A (en) 1995-04-28
AU663000B2 (en) 1995-09-21
FI933954A0 (fi) 1993-09-09
NZ248627A (en) 1995-01-27
CA2105913A1 (en) 1994-03-12

Similar Documents

Publication Publication Date Title
IL105283A0 (en) Stability-enhanced variants of parathyroid hormone,pharmaceutical compositions containing the same and methods for the preparation thereof
GB8729404D0 (en) Hydrosols of pharmacologically active agents & pharmaceutical compositions comprising them
FI971776L (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
HU9303035D0 (en) N-amino-alkyl-carbonyloxy-alkyl-pyrrol derivatives and insecticidal acaricidal and molluscicidal compositions containing the compounds as active ingredients
IL107978A0 (en) Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
CZ8193A3 (en) Pharmaceutical dosing form with prolonged release of active compound
NZ502280A (en) Combination therapy comprising atorvastatin and an antihypertensive agent
IL113818A0 (en) Pharmaceutical active cns compounds and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
HUP0001170A3 (en) Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer
IL75490A0 (en) Controlled release pharmaceutical compositions containing solid dispersions of active agent
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
ZA935532B (en) Crystalline amifostine compositions and methods for the preparation and use of same
IL108019A0 (en) Hydroxyiminoalkylindole-carboxylic acid derivatives their preparation and pharmaceutical compositions containing them
HUT64082A (en) Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient
EP0440809A4 (en) Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
IL105222A0 (en) Cyclohex-1-ene compounds and pharmaceutical compositions containing them
IL107449A0 (en) Compositions and methods for reducing toxicity and increasing the efficacy of drugs
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
AU4480889A (en) A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
AU3347893A (en) Retroreverse pyrrole-amidino oligopeptide anticancer agent analogues, preparation of same, and pharmaceutical compositions containing such analogues
HU900865D0 (en) Fungicidal compositions comprising 2-anilino-cyanopyridines and process for preparation of the active ingredient
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
CZ123595A3 (en) The use of xanthine derivatives for preparing pharmaceutical preparations and pharmaceutical compositions containing said derivatives
IL107611A0 (en) Steroid compounds and pharmaceutical compositions containing them